Cite

HARVARD Citation

    Epaillard, N. et al. (2021). Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie study. Lung cancer. pp. 114-119. [Online]. 
  
Back to record